SPOTLIGHT -
Solving the Drug Shortage Burden
Drug shortages might be decreasing, but their continued existence is urging the pharmacy industry to maintain its vigilance.
Biosimilars Need Access and Cost Examinations
Biologic medicines could lower spending by $153 billion by 2023.
Compounding Industry on the Newest MOU Draft
FDA plans to finalize the draft in 2019.
Changing Healthcare Environment Prompts New Roles for Pharmacists
Changes fueled by the 2003 Medicare Prescription Drug Improvement and Modernization Act.
Discount Drug Cards Are Flourishing
Programs increasingly cater to the uninsured and underinsured
Clinical Pharmacists Are Integral Team Members in PCMHs
Independent Pharmacies, Chains Enter Specialty Pharmacy
What needs to be considered before independent and chain pharmacies branch into the specialty arena.
Antimicrobial Stewardship Programs Need Pharmacist Expertise
Pharmacists are urged to adopt protocols to combat the constant rise of antibiotic resistance.